What is the recommended treatment for rhinitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Rhinitis

Intranasal fluticasone propionate 200 mcg once daily is the recommended treatment for allergic rhinitis in adults and adolescents, with a reduced dose of 100 mcg once daily for children aged 4-11 years. 1

Mechanism and Efficacy

Fluticasone propionate is a potent synthetic corticosteroid that works through anti-inflammatory mechanisms, though symptom relief is not immediate. 1 Key pharmacological points include:

  • Onset of action: Some patients experience symptom reduction within 12 hours, but maximum benefit typically requires several days of consistent use 1
  • The drug decreases nasal mucosal eosinophils in 66% of patients (versus 35% with placebo) and basophils in 39% of patients (versus 28% with placebo) 1
  • Fluticasone propionate is 3-5 fold more potent than dexamethasone in glucocorticoid receptor binding assays 1

Dosing Algorithm

Adults and adolescents:

  • Start with 200 mcg (2 sprays per nostril) once daily 1
  • Continue for at least several days to achieve maximum benefit 1

Children aged 4-11 years:

  • Use 100 mcg once daily 1
  • Safety and efficacy established for 2-4 week treatment periods 1

Safety Profile

The medication demonstrates excellent tolerability with minimal systemic absorption:

  • Absolute bioavailability is less than 2% via intranasal route 1
  • Plasma concentrations remain below detection limits (50 pg/mL) at recommended doses 1
  • Less than 2% of patients discontinued treatment due to adverse events in clinical trials 1
  • Most common adverse effects are local: headache (16.1%), pharyngitis (7.8%), epistaxis (6.9%), and nasal burning/irritation (3.2%) 1

Critical Drug Interaction

Avoid coadministration with ritonavir or other potent CYP3A4 inhibitors, as this dramatically increases systemic fluticasone exposure (plasma concentrations increased from undetectable to 318 pg/mL with ritonavir coadministration). 1

Important Caveats

  • Systemic corticosteroid effects were not reported in controlled trials up to 6 months duration at recommended doses 1
  • If recommended doses are exceeded or patients are particularly sensitive, Cushing syndrome could theoretically occur 1
  • Symptoms may persist for several days after discontinuation due to the drug's prolonged anti-inflammatory effects 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.